SURVIVAL BENEFIT ASSOCIATED WITH FLUOROPYRIMIDINES, PLATINUM AGENTS, TAXANES, AND IRINOTECAN DURING ALL LINES OF TREATMENT IN PATIENTS WITH ADVANCED GASTRIC CANCER

被引：0
|
作者：
Shitara, K. [1 ]
Matsuo, K. [2 ]
Takahari, D.
Yokota, T. [1 ]
Ura, T.
Ito, S.
Sawaki, A.
Tajika, M.
Kawai, H.
Muro, K.
机构：
[1] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi 464, Japan
[2] Aichi Canc Ctr Res Inst, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：228 / 229
页数：2
相关论文
共 50 条
  • [41] TRIPLET COMBINATION OF CAPECITABINE PLUS OXALIPLATIN AND IRINOTECAN IN THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED GASTRIC CANCER (AGC)
    Franceschelli, E. L.
    Celio, L.
    Colonna, V.
    Fossile, E.
    Ferrario, E.
    Valente, M.
    Ducceschi, M.
    Bajetta, E.
    ANNALS OF ONCOLOGY, 2010, 21 : 228 - 228
  • [42] Weekly treatment with irinotecan, folinic acid and infusional 5-fluorouracil (ILF) in patients with advanced gastric cancer
    Moehler, M
    Haas, U
    Siebler, J
    Schimanski, C
    Hertkorn, C
    Hoehler, T
    Galle, PR
    Heike, M
    ANTI-CANCER DRUGS, 2003, 14 (08) : 645 - 650
  • [43] Survival benefit associated with the number of chemotherapy/biologic treatment lines in 5,129 elderly metastatic colon cancer patients.
    Hanna, Nader
    Zheng, Zhiyuan
    Woods, Corinne
    Onukwugha, Ebere
    Bikov, Kaloyan A.
    Seal, Brian S.
    Mullins, C. Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
    Grothey, A
    Sargent, D
    Goldberg, RM
    Schmoll, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1209 - 1214
  • [45] Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients
    Pietrantonio, F.
    Biondani, P.
    Milione, M.
    Melotti, F.
    Bertarelli, G.
    Perrone, F.
    de Braud, F.
    Mariani, L.
    Fanetti, G.
    Cortinovis, D.
    Di Bartolomeo, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (07): : 582 - 586
  • [46] Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients
    F. Pietrantonio
    P. Biondani
    M. Milione
    F. Melotti
    G. Bertarelli
    F. Perrone
    F. de Braud
    L. Mariani
    G. Fanetti
    D. Cortinovis
    M. Di Bartolomeo
    Clinical and Translational Oncology, 2013, 15 : 582 - 586
  • [47] Survival Benefit of Traditional Chinese Herbal Medicine (a Herbal Formula for Invigorating Spleen) for Patients With Advanced Gastric Cancer
    Xu, Yan
    Zhao, Ai Guang
    Li, Zhao Yan
    Zhao, Gang
    Cai, Yong
    Zhu, Xiao Hong
    Cao, Ni Da
    Yang, Jin Kun
    Zheng, Jian
    Gu, Yin
    Han, Ying Ying
    Zhu, Ying Jie
    Yang, Jin Zu
    Gao, Feng
    Wang, Qiang
    INTEGRATIVE CANCER THERAPIES, 2013, 12 (05) : 414 - 422
  • [48] Survival Benefit of Three Different Therapies in Postoperative Patients With Advanced Gastric Cancer: A Network Meta-Analysis
    Wu, Dong-Mei
    Wang, Shan
    Wen, Xin
    Han, Xin-Rui
    Wang, Yong-Jian
    Shen, Min
    Fan, Shao-Hua
    Zhang, Zi-Feng
    Zhuang, Juan
    Shan, Qun
    Li, Meng-Qiu
    Hu, Bin
    Sun, Chun-Hui
    Lu, Jun
    Zheng, Yuan-Lin
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [49] Impact of tumor growth rate during preceding treatment on tumor response to nivolumab or irinotecan in advanced gastric cancer.
    Kato, Kyoko
    Masuishi, Toshiki
    Fushiki, Kunihiro
    Nakano, Shintaro
    Kawakami, Takeshi
    Kawamoto, Yasuyuki
    Narita, Yukiya
    Tsushima, Takahiro
    Nakatsumi, Hiroshi
    Kadowaki, Shigenori
    Todaka, Akiko
    Yuki, Satoshi
    Tajika, Masahiro
    Machida, Nozomu
    Komatsu, Yoshito
    Muro, Kei
    Yasui, Hirofumi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [50] IRINOTECAN PLUS 5-FLUOROURACIL BOLUS AND CONTINUOUS INFUSION AS SECOND-LINE TREATMENT IN PREVIOUSLY PLATINUM-TREATED PATIENTS WITH ADVANCED GASTRIC CANCER (AGC)
    Felici, A.
    Carlini, P.
    Ruggeri, E. M.
    De Marco, S.
    Moscetti, L.
    Vanni, B.
    Fariello, A. M.
    Sperduti, I.
    Cognetti, F.
    ANNALS OF ONCOLOGY, 2004, 15 : 74 - 75
12345